DEUTSCHE BANK AG\
BankPosition in PRAX — Praxis Precision Medicines, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in PRAX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$21,514,608
+$2,898,794 QoQ
Shares Held
64,263
+11.2% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 308 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. PRAX ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in PRAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,514,608 | 64,263 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $18,615,814 | 57,779 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $14,976,033 | 50,811 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $734,368 | 13,856 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $509,813 | 12,124 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $524,915 | 13,861 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,179,334 | 15,324 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $593,525 | 10,315 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $327,115 | 7,909 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $9,275 | 152 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $3,386 | 152 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,922 | 2,294 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,638 | 2,294 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,254 | 26,273 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,233 | 13,964 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,123 | 13,711 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,417 | 18,946 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $216,890 | 21,243 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $456,664 | 23,181 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $390,563 | 21,123 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $310,101 | 16,964 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $245,928 | 7,507 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $449,677 | 8,173 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||